Status:
UNKNOWN
Management of TA in VaS-Patients and HT
Lead Sponsor:
Xijing Hospital
Conditions:
VTE After Stroke
Eligibility:
All Genders
Brief Summary
Stroke is an independent risk factor for venous thrombosis (VTE), which leads to a significant increase in the mortality and disability rate after stroke. For patients with high risk factors for VTE s...
Eligibility Criteria
Inclusion
- Patients diagnosed with VTE after stroke
- Use at least one antithrombotic drug
Exclusion
- Case information is incomplete
- Non-spontaneous cerebral hemorrhage
- Suffer from serious blood system disease
- Do not accept follow-up
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04726007
Start Date
January 1 2018
End Date
December 1 2022
Last Update
January 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of the Air Force Medical University
Xi'an, Shaanxi, China, 710000